✦ LIBER ✦

Therapeutic effect of hepatocyte growth factor-secreting mesenchymal stem cell in established rat liver fibrosis model

✍ Scribed by Kim, Myung-Deok; Kim, Sung-Soo; Cha, Hyun-Young; Jang, Seunghun; Chang, Dayoung; Yang, Jongwock; Park, Bok-Nam; Yoon, Joon-Kee; Kim, Wook-Hwan; Suh-Kim, Haeyoung

Book ID: 109846799
Publisher: Nature Publishing Group
Year: 2008
Tongue: English
Weight: 304 KB
Volume: 18
Category: Article
ISSN: 0007-0610
DOI: 10.1038/cr.2008.245

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antifibrogenic effect of a deletion vari

Antifibrogenic effect of a deletion variant of hepatocyte growth factor on liver fibrosis in rats

✍ H Yasuda; E Imai; A Shiota; N Fujise; T Morinaga; K Higashio 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 847 KB

which may be modulated by the most potent fibrogenic cyto-Hepatic fibrosis, which may lead to cirrhosis, is associkine, transforming growth factor b 1 (TGF-b 1 ). 5,6 Hepatic fiated with most chronic liver diseases. Current therapies brosis is associated with an activation of lipocytes. 2 In hepatic

The therapeutic potential of human umbil

The therapeutic potential of human umbilical mesenchymal stem cells from Wharton's jelly in the treatment of rat liver fibrosis

✍ Pei-Chun Tsai; Tz-Win Fu; Yi-Ming Arthur Chen; Tsui-Ling Ko; Tien-Hua Chen; Yang 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 513 KB

We investigated the effect of human umbilical mesenchymal stem cells (HUMSCs) from Wharton's jelly on carbon tetrachloride (CCl 4 )-induced liver fibrosis in rats. Rats were treated with CCl 4 for 4 weeks, and this was followed by a direct injection of HUMSCs into their livers. After 4 more weeks of

Insulin-like growth factor 1 improves th

Insulin-like growth factor 1 improves the efficacy of mesenchymal stem cells transplantation in a rat model of myocardial infarction

✍ Jun Guo; Guosheng Lin; Cuiyu Bao; Zhimin Hu; Honggang Chu; Mingyan Hu 📂 Article 📅 2007 🏛 BioMed Central 🌐 English ⚖ 343 KB

Glial cell line-derived neurotrophic fac

Glial cell line-derived neurotrophic factor–secreting genetically modified human bone marrow-derived mesenchymal stem cells promote recovery in a rat model of Parkinson's disease

✍ Aleksandra Glavaski-Joksimovic; Tamas Virag; Thomas A. Mangatu; Michael McGrogan 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 456 KB 👁 1 views

## Abstract Parkinson's disease (PD) is a neurodegenerative disease characterized by progressive degeneration of nigrostriatal dopaminergic (DA) neurons. The therapeutic potential of glial cell line‐derived neurotrophic factor (GDNF), the most potent neurotrophic factor for DA neurons, has been dem

Diurnal dynamics of cell proliferation i

Diurnal dynamics of cell proliferation in rat liver during early postnatal ontogeny and effect of epidermal growth factor on hepatocyte proliferative activity

✍ S. N. Smirnov; V. B. Zakharov; S. G. Mamontov 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 263 KB

In vitro effects of low-level laser irra

In vitro effects of low-level laser irradiation for bone marrow mesenchymal stem cells: Proliferation, growth factors secretion and myogenic differentiation

✍ Jian-feng Hou; Hao Zhang; Xin Yuan; Jun Li; Ying-jie Wei; Sheng-shou Hu 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 278 KB 👁 1 views

## Abstract ## Background and Objectives Bone marrow derived mesenchymal stem cells (BMSCs) have shown to be an appealing source for cell therapy and tissue engineering. Previous studies have confirmed that the application of low‐level laser irradiation (LLLI) could affect the cellular process. Ho